A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - | - |
| Net Income | -15M | -15M | -28M | -29M | -34M | -39M |
| EPS | $-0.16 | $-0.16 | $-0.59 | $-0.63 | $-0.74 | $-0.96 |
| Free Cash Flow | -14M | -14M | -27M | -36M | -20M | -17M |
| ROIC | -116.1% | -116.1% | -256.9% | -3196.2% | -39.2% | -41.6% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | - | - | - | 1.15 | 1.57 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -17M | -17M | -32M | -29M | -33M | -29M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | 0.0% | - | - | -2093.0% | -208.7% | -289.5% |
| Shares Outstanding | 125M | 125M | 65,309M | 46M | 46M | 41M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | N/A | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | 26M | 27M | 20M | 21M | 13M | 13M |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -29M | -33M | -29M | -32M | -17M | -17M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -39M | -34M | -29M | -28M | -15M | -15M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | -41.6% | -39.2% | N/M | N/M | -116.1% | -116.1% |
| ROE | -289.5% | -208.7% | -2093.0% | N/A | N/A | 0.0% |
| ROA | -71.8% | -55.7% | -61.8% | -152.9% | -140.5% | -130.2% |
| Cash Flow | ||||||
| Op. Cash Flow | -17M | -20M | -36M | -27M | -14M | -14M |
| Free Cash Flow | -17M | -20M | -36M | -27M | -14M | -14M |
| Owner Earnings | -22M | -27M | -40M | -30M | -16M | -16M |
| CapEx | 7K | 38K | 265K | 11K | 1K | 1K |
| Maint. CapEx | 1.1M | 1.1M | 1.1M | 2.4M | 1.1M | 1.1M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 1.1M | 1.1M | 1.1M | 2.4M | 1.1M | 1.1M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 424K | 360K | 203K | 107K | 29K | 29K |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% |
| Stock-Based Comp | 4.0M | 5.7M | 3.5M | 637K | 847K | 847K |
| Debt Repayment | 0 | 3.6M | 8.2M | 0 | 2.3M | 2.3M |
| Balance Sheet | ||||||
| Net Debt | -22M | -31M | 17M | 15M | 15M | 15M |
| Cash & Equiv. | 44M | 52M | 11M | 2.3M | 2.7M | 2.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | 17M |
| Debt/Equity | 1.57 | 1.15 | N/A | N/A | N/A | 0.00 |
| Interest Coverage | -2.6 | -11.2 | -7.6 | -8.7 | N/A | N/A |
| Equity | 13M | 19M | -16M | -33M | -29M | -29M |
| Total Assets | 54M | 67M | 27M | 9.9M | 12M | 12M |
| Total Liabilities | 41M | 48M | N/A | N/A | N/A | N/A |
| Intangibles | N/A | N/A | N/A | 81K | 62K | 62K |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital | 31M | 37M | 8.7M | -20M | -19M | -19M |
| Current Assets | 50M | 63M | 24M | 7.1M | 5.8M | 5.8M |
| Current Liabilities | 20M | 26M | 15M | 27M | 24M | 24M |
| Per Share Data | ||||||
| EPS | -0.96 | -0.74 | -0.63 | -0.59 | -0.16 | -0.16 |
| Owner EPS | -0.55 | -0.58 | -0.87 | -0.00 | -0.13 | -0.13 |
| Book Value | 0.33 | 0.41 | -0.35 | -0.00 | -0.23 | -0.23 |
| Cash Flow/Share | -0.42 | -0.44 | -0.77 | -0.00 | -0.11 | -0.11 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 40.9M | 46.3M | 46.3M | 65.3B | 124.8M | 124.8M |
| Valuation | ||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | -0.5 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | -136.0% |
| Market Cap | 0 | 0 | 0 | 0 | 0 | 10M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
GENSIGHT BIOLOGICS passes 0 of 9 quality checks, indicating weak fundamentals.
Total shareholder yield (buybacks) is 0.3%.
GENSIGHT BIOLOGICS (SIGHT-PA) has a 5-year average return on invested capital (ROIC) of -65.7%. This is below average and may indicate limited pricing power.
GENSIGHT BIOLOGICS (SIGHT-PA) has a market capitalization of $10M. It is classified as a small-cap stock.
GENSIGHT BIOLOGICS (SIGHT-PA) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.28%.
GENSIGHT BIOLOGICS (SIGHT-PA) generated $-14 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
GENSIGHT BIOLOGICS (SIGHT-PA) reported earnings per share (EPS) of $-0.16 in its most recent fiscal year.
The Ledger Terminal provides 5 years of financial data for GENSIGHT BIOLOGICS (SIGHT-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
GENSIGHT BIOLOGICS (SIGHT-PA) has a book value per share of $-0.23, based on its most recent annual SEC filing.